Physician profile
Robert J Baranowski
NPI 1205892205
$2,131.92
in general payments reported to CMS, 2019-2025
20 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $93.04 · 2021: $24.22 · 2023: $250 · 2024: $566 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $322.84 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Abbvie INC. | $310.61 | 2019-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $203.34 | 2023-2025 | |
| Madrigal Pharmaceuticals | $186.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $185.04 | 2023-2025 | |
| Lilly USA, LLC | $140.05 | 2024-2025 | Omvoh |
| Janssen Biotech, INC. | $138.25 | 2019-2025 | Tremfya, Simponi, Stelara |
| Phathom Pharmaceuticals, INC. | $133.30 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.33 | 2019-2020 | |
| Ardelyx, INC. | $67.45 | 2024 | Ibsrela |
| Shionogi INC | $50.52 | 2019 | |
| Ironwood Pharmaceuticals, INC | $50.48 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $47.64 | 2019 | |
| Intercept Pharmaceuticals, INC. | $40.08 | 2023 | Ocaliva |
| Celgene Corporation | $32.45 | 2023 | Zeposia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $27.16 | 2025 | Vowst |
| Allergan, INC. | $27.08 | 2019 | |
| Medtronic, INC. | $24.22 | 2021 | |
| Shire North American Group INC | $23.50 | 2019 | |
| Boston Scientific Corporation | $19.98 | 2024 | Compliance Endokit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baranowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.